State Street’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77K | Sell |
61,600
-64,073
| -51% | -$80.1K | ﹤0.01% | 4019 |
|
|
2025
Q1 | $406K | Buy |
125,673
+9,879
| +9% | +$31.9K | ﹤0.01% | 3636 |
|
|
2024
Q4 | $477K | Buy |
115,794
+79,700
| +221% | +$328K | ﹤0.01% | 3628 |
|
|
2024
Q3 | $232K | Buy |
36,094
+17,967
| +99% | +$115K | ﹤0.01% | 3791 |
|
|
2024
Q2 | $87.2K | Buy |
+18,127
| New | +$87.2K | ﹤0.01% | 4045 |
|